Yüklüyor......
Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting
BACKGROUND: In the absence of long-term, placebo-controlled studies of cholinesterase inhibitors in Alzheimer’s disease (AD), analysis of the results of open-label trials becomes crucial. This study aimed to explore the three-year effects of galantamine treatment, as well as subgroups of response an...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3191869/ https://ncbi.nlm.nih.gov/pubmed/22003296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S24196 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|